Value Proposition and Franchise Optimization

Function Tailoring of a value proposition and access strategy for a new oncology therapy in Newly Diagnosed Multiple Myeloma (NDMM).
Challenge Optimal access strategy in NDMM
Impact Payer engagement and sequencing reshaped

Challenge

Client needed to assess the opportunity in NDMM for a new therapy and determine the optimal access strategy that will maximize franchise value across indications.

Approach

Scimitar completed a comparative assessment of competitors against various factors and payer / KOL interviews to quantifying perceptions / value. A targeted patient message assessment and segment was conducted to determine optimal communication and segments to tackle.

Impact

Delivered price potential assessments and cross‑functional implications that support re-shaping of payer engagement and launch sequencing.

Talk through a similar challenge.

Facing a version of this problem? Bring it to a conversation and we will walk through what it would take to make the change real.

Schedule a Conversation
Explore More Proof

Related Case Studies

See All Case Studies